Physician Resources

SAMHSA releases new guide on the use of medications for alcohol use disorder


 

References

A new guide on the use of medications to treat patients with alcohol use disorder has been released by the Substance Abuse and Mental Health Services Administration in conjunction with National Alcohol Awareness Month.

The guide provides an overview of four Food and Drug Administration–approved drugs developed to treat alcohol use disorder: disulfiram, oral naltrexone, extended-release injectable naltrexone, and acamprosate. It also discusses how to screen, treat, and monitor patients based on their individual needs.

“Current evidence shows that medications are underused in the treatment of alcohol use disorder,” the agency said in a statement announcing the new guidance. “As the Patient Protection and Affordable Care Act (ACA) continues to be implemented, there is considerable potential for expanding use of medication-assisted treatment to treat alcohol use disorder,” they concluded.

The guide can be found online at http://store.samhsa.gov.

Recommended Reading

Substance use disorders in adolescents with psychiatric comorbidity: When to screen and how to treat
MDedge Psychiatry
The common neurobiology of substances of abuse and sugar
MDedge Psychiatry
Substance use in adolescents
MDedge Psychiatry
Recurrent depression worsens odds of smoking cessation
MDedge Psychiatry
AAP against widespread drug testing in high schools
MDedge Psychiatry
Clonidine maintenance therapy extends opioid abstinence
MDedge Psychiatry
Female prisoners with addiction have high rates of comorbid mental disorders
MDedge Psychiatry
Identifying as a nonsmoker may help ex-smokers stay abstinent
MDedge Psychiatry
Executive function deficits linked to e-cigarette use in early adolescents
MDedge Psychiatry
FDA issues new industry guidance for abuse-deterrent opioids
MDedge Psychiatry